Dr Reddy's Laboratories Ltd

SWB:RDDA

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RDDA's stock price target?

Price Target

12.19 EUR

According to Wall Street analysts, the average 1-year price target for RDDA is 12.19 EUR with a low forecast of 9.37 EUR and a high forecast of 16.39 EUR.

What is the Revenue forecast for Dr Reddy's Laboratories Ltd?

Projected CAGR

8%

Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 4 years is 8%.

What is the Gross Profit forecast for Dr Reddy's Laboratories Ltd?

Projected CAGR

3%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 4 years is 3%.

What is the Operating Income forecast for Dr Reddy's Laboratories Ltd?

Projected CAGR

1%

Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 4 years is 1%.

What is the Pre-Tax Income forecast for Dr Reddy's Laboratories Ltd?

Projected CAGR

-1%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is -1%.

What is the Net Income forecast for Dr Reddy's Laboratories Ltd?

Projected CAGR

2%

Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 4 years is 2%.